The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Tuberculosis case fatality rates in high HIV prevalence populations in sub-Saharan Africa
Abstract
BACKGROUND: Tuberculosis is a leading cause worldwide of morbidity and mortality among HIV-infected people. The HIV era has seen a dramatic increase of the tuberculosis case fatality rate (CFR) in high HIV prevalence populations. Providing care for HIV-infected people must include measures to tackle this high tuberculosis CFR. AIMS: To analyse the extent of the increased tuberculosis CFR in high HIV prevalence populations in sub-Saharan Africa, the reasons for this increase and the causes of death, in order to identify possible ways of tackling this problem. METHODS: References were obtained by searching the MEDLINE on 'tuberculosis', 'HIV infection', and 'mortality' (MesH or textword). In addition, available data from National Tuberculosis Programme reports were reviewed. FINDINGS: Tuberculosis CFR is closely linked to HIV prevalence. Limited autopsy data suggest that death from HIV-related diseases other than tuberculosis is probably the main reason for the increased CFR in HIV-infected tuberculosis patients. Among HIV-infected tuberculosis patients, the higher tuberculosis CFR in sputum smear-negative and extrapulmonary than in sputum smear-positive tuberculosis cases can also be attributed to misdiagnosis of HIV-related diseases as tuberculosis. The adverse effect of the HIV/AIDS epidemic on general health service performance probably accounts for the higher tuberculosis CFR among HIV-negative tuberculosis patients in high prevalence populations than that in low HIV-prevalence populations. CONCLUSION: Tackling the problem of the increased tuberculosis CFR in high HIV prevalence populations requires collaboration between tuberculosis control and HIV/AIDS programmes in implementing measures such as improved health services, tuberculosis and HIV control services, preventive treatment for HIV-related diseases and anti-HIV treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Palella, F. J., Delaney, K. M., Moorman, A. C., Loveless, M. O., Fuhrer, J., Satten, G. A., Aschman, D. J., & Holmberg, S. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803263381301 · Cited by 9,405
Global Burden of Tuberculosis: Estimated Incidence, Prevalence, and Mortality by Country
Dye, C., Scheele, S., >Dolin, P., Pathania, V., Raviglione, M. C., & for the WHO Global Surveillance and Monitoring Project (1999) · JAMA · doi:10.1001/jama.282.7.677 · Cited by 2,947
Selwyn, P. A., Hartel, D., Lewis, V. A., Schoenbaum, E. E., Vermund, S. H., Klein, R. S., Walker, A. T., & Friedland, G. H. (1989) · New England Journal of Medicine · doi:10.1056/nejm198903023200901 · Cited by 1,574
Changing patterns of mortality across Europe in patients infected with HIV-1
Mocroft, A., Vella, S., Benfield, T., Chiesi, A., Miller, V, Gargalianos, P., Monforte, A. D., Yust, I., Bruun, J., Phillips, A., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(98)03201-2 · Cited by 1,270
Daley, C. L., Small, P. M., Schecter, G. F., Schoolnik, G. K., McAdam, R. A., Jacobs, W. R., & Hopewell, P. C. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201233260404 · Cited by 986
Global tuberculosis incidence and mortality during 1990-2000.
Pj, D., Raviglione, M. C., & Kochi, A. (1994) · PubMed · Cited by 768
The mortality and pathology of HIV infection in a West African city
Lucas, S. B., Hounnou, A., Peacock, C., Beaumel, A., Djomand, G., NʼGbichi, J.-M., Yeboue, K., Hondé, M., Diomande, M., Giordano, C., et al. (1993) · AIDS · doi:10.1097/00002030-199312000-00005 · Cited by 562
Accelerated course of human immunodeficiency virus infection after tuberculosis.
Whalen, C., Horsburgh, C. R., Hom, D., Lahart, C., Simberkoff, M., & Ellner, J. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.151.1.7812542 · Cited by 535
Wiktor, S. Z., Sassan-Morokro, M., Grant, A. D., Abouya, L., Karon, J. M., Maurice, C., Djomand, G., Ackah, A., Domoua, K., Kadio, A., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(99)03465-0 · Cited by 418
Anglaret, X., Chêne, G., Attia, A., Toure, S., Lafont, S., Combe, P., Manlan, K., N'Dri-Yoman, T., & Salamon, R. (1999) · The Lancet · doi:10.1016/s0140-6736(98)07399-1 · Cited by 404
Research works printed but not linked: 18
- Buhl, 1967, Bull World Health Org, 37, 907
- Malkin, 1997, Int J Tuberc Lung Dis, 1, 68
- Garin, 1997, Lancet, 350, 1298, 10.1016/S0140-6736(05)62475-0 · doi:10.1016/s0140-6736(05)62475-0
- Banerjee, 1997, Trans Roy Soc Trop Med, 91, 707, 10.1016/S0035-9203(97)90533-2 · doi:10.1016/s0035-9203(97)90533-2
- Dolin, 1994, Bull World Health Org, 72, 213
- Moorman, 1999, Int J Tuberc Lung Dis, 3, 786
- Kruyt, 1999, Bull World Health Org, 77, 386
- Connolly, 1998, Int J Tuberc Lung Dis, 2, 919
- van den, 1998, Int J Tuberc Lung Dis, 2, 547
- Wilkinson, 1996, S Afr Med J, 86, 64
- Kool, 1990, Trop Geogr Med, 42, 128
- Kelly, 1999, Trans Roy Soc Trop Med Hyg, 93, 287, 10.1016/S0035-9203(99)90025-1 · doi:10.1016/s0035-9203(99)90025-1
- Whalen, 1996, Am J Respir Crit Care Med, 153, 1977, 10.1164/ajrccm.153.6.8665064 · doi:10.1164/ajrccm.153.6.8665064
- Elliott, 1995, J Trop Med Hyg, 98, 9
- Berning, 1992, N Engl J Med, 327, 1817, 10.1056/NEJM199212173272514 · doi:10.1056/nejm199212173272514
- Taylor, 1998, Int J Tuberc Lung Dis, 2, 670
- Badri, 1999, Lancet, 354, 334, 10.1016/S0140-6736(05)75237-5 · doi:10.1016/s0140-6736(05)75237-5
- 1999, Lancet, 354, 116, 10.1016/S0140-6736(98)10448-8 · doi:10.1016/s0140-6736(98)10448-8
Cited by
The Growing Burden of Tuberculosis: Global Trends and Interactions With the HIV Epidemic
Corbett, E. L., Watt, C. J., Walker, N., Maher, D., Williams, B. G., Raviglione, M. C., & Dye, C. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.9.1009 · Cited by 2,553
Self-citationGandhi, N. R., Moll, A., Sturm, A. W., Pawinski, R., Govender, T., Lalloo, U., Zeller, K., Andrews, J., & Friedland, G. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69573-1 · Cited by 1,732
Boehme, C. C., Nicol, M. P., Nabeta, P., Michael, J. S., Gotuzzo, E., Tahirli, R., Gler, M. T., Blakemore, R., Worodria, W., Gray, C., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60438-8 · Cited by 1,013
HIV and Tuberculosis: a Deadly Human Syndemic
Kwan, C. K., & Ernst, J. D. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00042-10 · Cited by 720
Timing of Initiation of Antiretroviral Drugs during Tuberculosis Therapy
Abdool Karim, S. S., Naidoo, K., Grobler, A., Padayatchi, N., Baxter, C., Gray, A., Gengiah, T., Nair, G., Bamber, S., Singh, A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0905848 · Cited by 666
Metadata
- Authors
- Mukadi, Y. D., Maher, D., & Harries, A.
- Venue
- AIDS
- Published
- 2001-01
- Volume
- 15
- Issue
- 2
- Pages
- 143-152
- ISSN
- 0269-9370 (ISSN-L)
- OpenAlex
- W2079716870
- Cited by
- 311
- References
- 36
- FWCI
- 7.85
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Tuberculosis case fatality rates in high HIV prevalence populations in sub-Saharan Africa. https://app.cochat.ai/papers/10.1097/00002030-200101260-00002
- The paper
- Mukadi, Y. D., Maher, D., & Harries, A. (2001). Tuberculosis case fatality rates in high HIV prevalence populations in sub-Saharan Africa. AIDS. https://doi.org/10.1097/00002030-200101260-00002
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.